DR LAL PATHLABS
Back to Income Statement
|
DR LAL PATHLABS Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Income | ₹2,461 Cr | ₹2,227 Cr | ₹2,017 Cr | ₹2,087 Cr | ₹1,581 Cr |
What is the latest Revenue of DR LAL PATHLABS ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹2,461 Cr |
| Mar2025 | ₹2,227 Cr |
| Mar2024 | ₹2,017 Cr |
| Mar2023 | ₹2,087 Cr |
| Mar2022 | ₹1,581 Cr |
How is Revenue of DR LAL PATHLABS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,461 Cr | 10.54 | |
| Mar2025 | ₹2,227 Cr | 10.40 | |
| Mar2024 | ₹2,017 Cr | -3.38 | |
| Mar2023 | ₹2,087 Cr | 32.01 | |
| Mar2022 | ₹1,581 Cr | - | |
Compare Revenue of peers of DR LAL PATHLABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR LAL PATHLABS | ₹33,711.0 Cr | 2.2% | 5.1% | 31% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹122,382.0 Cr | 0.8% | 8.1% | 12.5% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹91,979.4 Cr | 1.2% | 9.5% | -18.6% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹64,168.2 Cr | 3.3% | 6.8% | 4.4% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹57,376.8 Cr | -0.9% | 0.5% | -24.6% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹37,564.6 Cr | -3.4% | 9% | 3.1% | Stock Analytics | |
DR LAL PATHLABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR LAL PATHLABS | 2.2% |
5.1% |
31% |
| SENSEX | 3.3% |
13.9% |
-1.7% |
You may also like the below Video Courses